Bruceine A

CAS : 25514-31-2

Ref. 3D-FB74247

Informations sur le produit

• Nom: Bruceine A
• Synonymes: 2H-3,11cβ-(Epoxymethano)phenanthro[10,1-bc]pyran-3α(1H)-carboxylic acid, 3a,4,5,6aβ,7,7aα,10,11,11a,11bα-decahydro-1β,2α,4β,9-tetrahydroxy-8,11aβ-dimethyl-5,10-dioxo-, methyl ester, 4-isovalerate, Brucein A, Dihydrobrusatol, Methyl (11beta,12alpha,15beta)-3,11,12-trihydroxy-15-[(3-methylbutanoyl)oxy]-2,16-dioxo-13,20-epoxypicras-3-en-21-oate, NSC 310616, Picras-3-En-21-Oic Acid, 13,20-Epoxy-3,11,12-Trihydroxy-15-(3-Methyl-1-Oxobutoxy)-2,16-Dioxo-, Methyl Ester, (11Beta,12Alpha,15Beta)-, Picras-3-en-21-oic acid, 13,20-epoxy-3,11,12-trihydroxy-15-(3-methyl-1-oxobutoxy)-2,16-dioxo-, methyl ester, (11β,12α,15β)-

Description

Bruceine A is a natural compound that is extracted from the root of Astragalus membranaceus. Bruceine A has been shown to have anticancer and anti-inflammatory activities in vitro. It inhibits cancer cells by binding to hydroxyl groups on their surfaces, inhibiting cellular respiration and inducing apoptosis. The compound also has anti-hepatitis and anti-cancer effects in vivo. Bruceine A inhibits the growth of hepatic cancer cells by suppressing the synthesis of fatty acids, which are necessary for cell proliferation. Bruceine A also inhibits cervical cancer cell proliferation by inhibiting the production of proteins that promote tumor growth.

• Marque: Biosynth

Propriétés chimiques

• Degré de pureté: Min. 95%